We are live on ! Find out more
SC

Samlyn Capital Portfolio holdings

AUM $6.14B
1-Year Est. Return 42.05%
This Fund
S&P 500
This Quarter Est. Return
+6.97%
1 Year Est. Return
+42.05%
3 Year Est. Return
+148.08%
5 Year Est. Return
+210.34%
10 Year Est. Return
+1,110.53%
AUM
$4.42B
AUM Growth
+$145M
Cap. Flow
+$47.6M
Cap. Flow %
1.08%
Top 10 Hldgs %
24.99%
Holding
172
New
48
Increased
42
Reduced
33
Closed
49

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$87.9M
2
EA
Electronic Arts
EA
+$70.8M
3
MA icon
Mastercard
MA
+$70.1M
4
AVGO icon
Broadcom
AVGO
+$59.3M
5
NOMD icon
Nomad Foods
NOMD
+$55.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.22%
2 Financials 19.34%
3 Healthcare 13.68%
4 Communication Services 10.3%
5 Industrials 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATH
1
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$152M 3.45%
2,948,201
-158,873
-5% -$7.66M
LPLA icon
2
LPL Financial
LPLA
$28.4B
$135M 3.05%
2,088,557
+272,643
+15% +$18.1M
TFCF
3
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$124M 2.8%
+2,705,437
New +$123M
STZ icon
4
Constellation Brands
STZ
$22B
$124M 2.8%
573,973
+197,812
+53% +$42.1M
APD icon
5
Air Products & Chemicals
APD
$67.7B
$108M 2.43%
643,715
+244,294
+61% +$39.8M
SEE
6
DELISTED
Sealed Air
SEE
$106M 2.41%
2,648,449
+445,000
+20% +$18.4M
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.15T
$99.9M 2.26%
1,674,920
+798,900
+91% +$47.9M
HLT icon
8
Hilton Worldwide
HLT
$70.7B
$89.3M 2.02%
1,105,761
-458,629
-29% -$36.1M
BURL icon
9
Burlington
BURL
$16.2B
$85.2M 1.93%
523,141
+331,234
+173% +$52.9M
MRK icon
10
Merck
MRK
$376B
$81.6M 1.85%
1,205,239
-1,380,017
-53% -$87.9M
TMO icon
11
Thermo Fisher Scientific
TMO
$229B
$79.8M 1.8%
326,795
-77,424
-19% -$17.8M
AVGO icon
12
CALL
Broadcom
AVGO
$1.7T
$77.1M 1.74%
+3,125,000
New +$70.1M
AMZN icon
13
Amazon
AMZN
$2.79T
$74.5M 1.68%
743,400
-244,260
-25% -$23M
TMUS icon
14
T-Mobile US
TMUS
$202B
$73.5M 1.66%
1,047,004
-813,233
-44% -$52.3M
SIVB
15
DELISTED
SVB Financial Group
SIVB
$72.9M 1.65%
234,444
+167,067
+248% +$52.7M
UNH icon
16
UnitedHealth
UNH
$360B
$71.6M 1.62%
269,307
-54,563
-17% -$14.2M
AGN
17
DELISTED
Allergan plc
AGN
$70.2M 1.59%
368,534
+57,928
+19% +$10.6M
TJX icon
18
TJX Companies
TJX
$145B
$68.7M 1.55%
1,225,892
+865,508
+240% +$44.5M
EFX icon
19
Equifax
EFX
$22.2B
$66.1M 1.5%
506,411
+183,764
+57% +$23.9M
BIIB icon
20
Biogen
BIIB
$33.2B
$65.1M 1.47%
184,251
+103,659
+129% +$35.7M
CPRI icon
21
Capri Holdings
CPRI
$1.5B
$63.7M 1.44%
929,397
+313,495
+51% +$22M
BRSL
22
Brightstar Lottery PLC
BRSL
$2.07B
$62M 1.4%
3,138,696
+864,314
+38% +$18.8M
W icon
23
Wayfair
W
$13.3B
$61.2M 1.38%
+414,269
New +$52.7M
USFD icon
24
US Foods
USFD
$22.6B
$61.1M 1.38%
1,983,965
+454,302
+30% +$15.7M
VOYA icon
25
Voya Financial
VOYA
$9.5B
$61.1M 1.38%
1,229,412
+231,220
+23% +$11.4M

Similar funds

Samlyn Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Samlyn Capital held 172 positions worth $4.42B, up 3.4% from $4.28B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Samlyn Capital's Q3 2018 filing shows 48 new, 42 increased, 33 reduced and 49 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 2,705,437 shares worth $124M. The largest sale was Merck, an estimated $87.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Samlyn Capital's largest Q3 2018 buy was Twenty-First Century Fox, Inc. Class B: 2,705,437 shares worth $124M.
  • Samlyn Capital added most to Burlington in Q3 2018, an estimated $52.9M increase.
  • Samlyn Capital's biggest Q3 2018 reduction was Merck, cutting an estimated $87.9M.
  • Samlyn Capital fully exited Nomad Foods in Q3 2018, selling an estimated $55.1M.
  • Samlyn Capital's ten largest holdings make up 25% of its $4.42B portfolio in Q3 2018.
  • Samlyn Capital opened 48 new positions and closed 49 in Q3 2018.
  • Samlyn Capital's portfolio value rose 3.4% quarter-over-quarter to $4.42B.

Based on Samlyn Capital's 13F filing for Q3 2018, filed 14 Nov 2018.